COMMUNICATED. Kidney diseases: recognized quality of care but a counter signal in pricing policy

19 care units were visited by HAS experts. UNSPLASH ILLUSTRATION. – Olga Kononenko

After the examination of expert visitors from the High Health Authority from November 20 to 24, 2023, the Charles Mion Foundation – Aider Santé and GCS Help have been certified with High Quality of Care.

After a week of visits by visiting experts from the High Authority of Health from November 20 to 24, 2023, within 19 care units of the establishment, the Charles Foundation Mion – AIDER Santé* and GCS Help**, establishments specializing in the management of kidney diseases in Occitanie, have been certified with the distinction High quality of care.

"A distinction which reflects your commitment and that of your teams, in the continuous improvement of the quality and safety of care. The absence of anomaly and results which tend towards the target of 100% on the chapters, objectives and criteria, particularly those advanced, played a determining role in this decision."

An overall score of 98.75%

The overall score is 98.75%, thanks to strong team cohesion and strong commitment to patients.

The Charles Mion-AIDER Santé Foundation and the GCS HELP display an overall score of satisfaction with the benchmark expectations of 98.75%: "This result is that of the involvement of each and everyone, of collaborative work at all times and of a recognized collective performance driven by strongly anchored values. We also thank the users, patients and their representatives", says Bernard Branger, President of the Foundation.

In order to evaluate the level of quality and security of the support of the Foundation and GCS Help, 8 experts HAS visitors observed practices and conducted interviews with governance, field teams, user representatives and patients, which represents nearly 100 audits.

4 major issues

The concepts evaluated by the visiting experts are established according to 4 associated issues: patient engagement, the culture of evaluating relevance and results, work in team and governance of the establishment, structured around 3 chapters and 95 criteria applicable to the establishment.

Accreditation obtained from 2023

This distinction, in continuityé previous ones obtained from the HAS, are added to this list. accreditation obtained in 2023 (Accreditation n°1-7216, scope available on www.cofrac.fr) according to standard NF EN ISO/CEI 17025 (2017) ) from the Environmental Hygiene laboratory of Aider Sant&eac;, piloted by by H&lène Beaussart, pharmacist, as well as the Qualiopi label of the training organization of the establishment, Aider santé training.

With the aim of continuing the dynamic of continuous improvement of an integrated quality approach, areas for improvement are to be worked on: "The requirements are more complex , and new challenges, such as digital, the environment and the 'culture of relevance' must be met with the same dynamism and the same pride of place. provide the highest quality of care to everyone, patients and healthcare professionals alike" continues Anne-Valérie Boulet, General Director of the establishment.

Quality recognition

Recognition of quality and yet a drop in funding and no resources to finance salary increases in theory granted to private non-profit establishments.

The establishment works at the integration of future issues, through its new establishment project which sets the 2024-2028 objectives in line with territorial needs, national issues but also the maintenance of the quality of the service provided by the Foundation, recognized as being of public utility.

"However, the Foundation is one of the establishments whose mission is unfortunately not recognized since it is financed on the private tariff scale, with a price increase of 0.3 % which does not include any transposition of salary measures, although announced as acquired by the non-profit private sector, no consideration of the inflation experienced…"  concludes Anne-Valérie Boulet.

Price policy 2024

The establishment is in fact one of the non-profit private establishments historically qualified as ex-OQN. However, the prices for care services remain differentiated according to this classification (Ex-OQN falling under the private scale and ex-DG falling under the ;public scale).

In the 2024 pricing policy, it appears that the same dialysis treatment according to the same modalities, for a patient in every respect similar, the public establishment sees its prices increased by 4.3& ;nbsp;% while private non-profit establishments, ex-OQN, only receive 0.3%. The Charles Mion-AIDER Santé Foundation, recognized as being of public utility, nevertheless contributes to the healthcare offering in 6 departments in cooperation with stakeholders, serving accessibility and the gradation of care.

"Taking into account only the foreseeable inflation over the period, this is actually a loss of around 3’ nbsp;% of our resources that we must face, jeopardizing the care of patients in our local establishments and their employees."

A measure experienced by these establishments, including the Charles Mion-Aider Santé Foundation, as a inequity of treatment to the detriment of patients.